Clinical and morphological aspects of the development of secondary ophthalmic hypertension in uveal melanoma

QR Code

Clinical and morphological aspects of the development of secondary ophthalmic hypertension in uveal melanoma

Ophthalmic hypertension is mostly associated with medium- or large-sized melanomas. The pathogenesis of persistent IOP elevation in uveal melanoma is not fully understood at present. Purpose. To analyze the clinical and morphological mechanisms of the development of secondary ophthalmic hypertensi...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. E. Grishina, G. R. Setdikova, I. D. Kim, A. M. Bogatyrev, I. A. Loskutov, E. R. Eremeeva
Format:	Article
Language:	Russian
Published:	Real Time Ltd 2022-07-01
Series:	Российский офтальмологический журнал
Subjects:	secondary ophthalmic hypertension pathogenesis intraocular pressure uveal melanoma neovascularization
Online Access:	https://roj.igb.ru/jour/article/view/984
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Circulating tumor DNA. Modern views about the possibility of use in uveal melanoma
by: A. M. Bogatyrev, et al.
Published: (2025-03-01)

Current Therapies and Potential Strategies for Uveal Melanoma
by: Sarah Scoles, et al.
Published: (2025-04-01)

Melanoma uveal primario a propósito de un caso
by: Alejandro Jarol Pavón Rojas, et al.
Published: (2025-06-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
by: B. I. Dolgushin, et al.
Published: (2016-09-01)

Epidemiology of neoplasms of the eye and adnexa in Orenburg region
by: A. E. Aprelev, et al.
Published: (2022-09-01)

SUBPOPULATION COMPOSITION OF PERIPHERAL BLOOD LYMPHOCYTES IN UVEAL MELANOMA
by: Svetlana Vladimirovna Saakyan, et al.
Published: (2019-10-01)

Аngiogenesis in Uveal Melanoma
by: V. G. Likhvantseva, et al.
Published: (2021-10-01)

PRIMARY ENDOPROSTHETIC REPLACEMENT OF THE ANOPHTHALMIC ORBIT IN PATIENTS WITH UVEAL MELANOMA: SIX-YEAR FOLLOW-UP RESULTS
by: A. A. Yarovoy, et al.
Published: (2015-04-01)

Immunohistochemical analysis of prame expression as a prognostic factor in uveal melanoma patients
by: S. V. Saakyan, et al.
Published: (2021-12-01)

Expression of Vascular Endothelial Growth Factor in Uveal Melanoma
by: V. G. Likhvantseva, et al.
Published: (2021-12-01)

JUXTAPAPILLARY CHOROIDAL MELANOMA
by: A. S. Stoyukhina
Published: (2015-04-01)

Liquid Biopsy for Uveal Melanoma. Does It Make Sense?
by: V. E. Ovanesyan, et al.
Published: (2022-10-01)

Immunohistochemical study of uveal melanoma and its cellular microenvironment
by: S. V. Saakyan, et al.
Published: (2022-06-01)

ANALYSIS OF METASTASES AND SURVIVAL RATES IN PATIENTS WITH UVEAL MELANOMA
by: S. V. Saakyan, et al.
Published: (2015-04-01)

Intraocular Medulloepitheliomae (Clinical Case Series)
by: S. V. Saakyan, et al.
Published: (2020-11-01)

Prognostic fine needle aspiration biopsy of uveal melanoma: Molecular and genetic factors of metastasis risk
by: V. A. Yarovaya, et al.
Published: (2023-10-01)

Comprehensive analysis of chromosome 8 abnormalities and its prognostic value in patients with uveal melanoma
by: V. A. Yarovaya, et al.
Published: (2022-03-01)

THE SURVIVAL RATE OF PATIENTS FOLLOWING UVEAL MELANOMA EYEBALL REMOVAL IN PERM REGION
by: T. V. Gavrilova, et al.
Published: (2017-07-01)

Study of the Phenotype of Endothelial Cells in the Vessels of Uveal Melanoma
by: V. G. Likhvantseva, et al.
Published: (2023-01-01)

Hybrid Photodynamic Therapy as a Component of Combined Treatment of Uveal Melanoma (Preliminary Results)
by: E. V. Boiko, et al.
Published: (2024-12-01)

Features of the Composition of Cytokines of Various Biological Effects in Patients with Uveal Melanoma: Analysis of Blood Serum. Part 2
by: V. V. Neroev, et al.
Published: (2022-07-01)

Possibilities for Identifying the Malignant Vasculature of Choroidal Melanoma
by: E. V. Samkovich, et al.
Published: (2020-06-01)

Features of the Composition of Cytokines of Various Biological Effects in Patients with Uveal Melanoma: Local Changes in the Lacrimal Fluid. Part 1
by: V. V. Neroev, et al.
Published: (2022-04-01)

Long-term survival of uveal melanoma patients with respect to clinical, hemodynamic and morphological characteristics of the tumor
by: S. V. Saakyan, et al.
Published: (2022-07-01)

Cellular and molecular characterization of γδ T cells in peripheral blood from patients with metastases from cutaneous and uveal melanoma
by: Tamara Alonso-Agudo, et al.
Published: (2025-07-01)

Advances in immunotherapy for uveal melanoma: enhancing efficacy and overcoming resistance
by: Jian Song, et al.
Published: (2025-06-01)

Acute effects of high-intensity interval training on microvascular circulation: a case control study in uveal melanoma
by: Mendes Wefelnberg Michael, et al.
Published: (2024-11-01)

Meta-analysis of uveal melanoma genome-wide association studies identifies novel risk loci and population effect size heterogeneity
by: Georgia Mies, et al.
Published: (2025-07-01)

The Possibilities of Modern Ultrasound Scanning in Uveal Melanoma Extrascleral Growth Detection
by: A. G. Amiryan, et al.
Published: (2022-10-01)

HEREDITARY UVEAL MELANOMA: A REVIEW OF LITERATURE AND A CASE REPORT
by: A. V. Semyanikhina, et al.
Published: (2018-05-01)

Clinical and morphological features and the assessment of survival in patients with iris melanoma
by: S. V. Saakyan, et al.
Published: (2024-03-01)

Isolated chemohyperthermal perfusion of the liver with melphalan in the treatment of unresectable liver metastases with uveal melanoma
by: A. D. Kaprin, et al.
Published: (2021-12-01)

Indications for enucleation after uveal melanoma brachytherapy
by: S. V. Saakyan, et al.
Published: (2018-10-01)

Isolated Transpupillary Photodynamic Therapy in Local Treatment of Choroidal Melanoma
by: I. E. Panova, et al.
Published: (2025-03-01)

Current Topics on the Integration of Artificial Intelligence in the Histopathological and Molecular Diagnosis of Uveal Melanoma
by: Serena Salzano, et al.
Published: (2025-04-01)

Low-Dose Quercetin Dephosphorylates AKT and Suppresses Proteins Related to Migration in Human Metastatic Uveal Melanoma Cells
by: Petra Fodor, et al.
Published: (2025-06-01)

Scleral necrosis after brachytherapy of uveal melanoma and methods of its elimination
by: S. V. Saakyan, et al.
Published: (2018-10-01)

The role of PET/CT in the diagnosis of metastatic uveal melanoma
by: S. V. Saakyan, et al.
Published: (2018-10-01)

VEGF-R1/Flt-1 Receptor as a Characteristic of the Angiogenic Phenotype of Uveal Melanoma
by: V. G. Likhvantseva, et al.
Published: (2021-12-01)

Integrating pathomics and deep learning for subtyping uveal melanoma: identifying high-risk immune infiltration profiles
by: Qi Wan, et al.
Published: (2025-07-01)